AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2012
May 21, 2012
35323_dirs_2012-05-21_b944b602-d935-46ba-8684-310e3744c022.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2012-05-18
Reporting Person: FELDMAN FREDRIC J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-18 | Stock Option (Right to Buy) | $0.17 | A | 35000 | Acquired | 2022-05-18 | Common Stock (35000) | Direct |
Footnotes
F1: 50% vest immediately and 50% on 5/18/2013
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16